Can Fite Biopharma
CANF
$1.94
Share price
-1.52%
Change (1 day)
14.12%
Change (1 year)
Categories
Operating Margin for Can Fite Biopharma (CANF)
Operating Margin as of April 2024 (TTM): -1,255.92%
According to Can Fite Biopharma 's latest financial reports and stock price the company's current Operating Margin is -1,255.92%. At the end of 2021 the company had an Operating Margin of -1,505.51%.
Operating Margin history for Can Fite Biopharma from 2011 to 2022
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | -1,505.51% | -18.42% |
| 2020 | -1,845.35% | 309.72% |
| 2019 | -450.39% | 180.21% |
| 2018 | -160.73% | -81.59% |
| 2017 | -873.13% | -78.75% |
| 2016 | -4,109.20% | 50.55% |
| 2015 | -2,729.39% | |
| 2011 | -1,023.25% | 111.58% |
| 2010 | -483.62% |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.